Amylin proposes follow-on

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) proposed late Wednesday to sell 13 million shares in a follow-on underwritten by Credit Suisse. If sold at Amylin's close of $16.17 on Wednesday, the company ...